Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 591-595

  Li, Hsing Hui ^a   Lin, Y C ^b   Chen, P J ^a   Hsiao, C H ^d   Lee, J Y Y ^a   Chen, W C ^c   Tzung, T Y ^e   Wu, J C ^e   Chang, Ming Shi ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Interleukin 19; Keratinocyte growth factor; Keratinocytes; Psoriasis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 20; KERATINOCYTE GROWTH FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE;

CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKINS; KERATINOCYTES; POLYMERASE CHAIN REACTION; PSORIASIS; RNA, MESSENGER; UP-REGULATION;

EID: 24344439870     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06665.x     Document Type: Article

References (13)

1. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al. The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 2001; 126:365-9.
2. Finch PW, Murphy F, Cardinale I et al. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 1997; 151:1619-28.
3. Strange P, Cooper KD, Hansen ER et al. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 1993; 101:695-700.
4. Gallagher G, Dickensheets H, Eskdale J et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000; 1:442-50.
5. Fickenscher H, Hor S, Kupers H et al. The interleukin-10 family of cytokines. Trends in Immunol 2002; 23:89-96.
6. Liao YC, Liang WG, Chen FW et al. IL-19 induces production of IL-6 and TNF-α and results in cell apoptosis through TNF-α. J Immunol 2002; 169:4288-97.
7. Dumoutier L, Leemans C, Lejeune D et al. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001; 167:3545-9.
8. Romer J, Hasselager E, Norby PL et al. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol. J Invest Dermatol 2003; 121:1306-11.
9. Goding JW. Monoclonal Antibodies. Principles and Practice. Production and Application of Monoclonal Antibodies in Cell Biology. Biochemistry, and Immunology. London: Academic Press 1983.
10. Ghoreschi K, Thomas P, Breit S et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9:40-6.
11. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999; 155:145-58.
12. Blumberg H, Conklin D, Xu WF et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001; 104:9-19.
13. Gallagher G, Eskdale J, Jordan W et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 2004; 4:615-26.